Biotherapeutics, Inc.
Last verified 2026-05-05. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $1.9Mattributed |
|---|---|
| Latest round | grant, $1.9M, 2025-09-01attributed |
| Founded | 2008 |
| Headquarters | Blacksburg, Virginia, USA |
| Industry | bio |
| Stage | unknown |
| Website | biotherapeuticsinc.com |
BioTherapeutics is a precision-medicine biotech running iMed, a computational platform that simulates synthetic IBD patient cohorts and predicts therapeutic response, alongside an abscisic-acid glycemic-control program for pre-diabetes. It serves pharma partners running early discovery and pre-diabetic patients. Founded 2008, integrating nutritionals, therapeutics, and IT.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2025-09-01 | grant | $1.9M | undisclosed |
Detected tech stack
Apache HTTP Server, jQuery CDN, ExpressionEngine, CodeIgniter, PHP, jquery 2.1.4, apache
Provenance
| Fact | Status | Basis |
|---|---|---|
| Grant, $1.9M | attributed | sbir named as publisher. No document URL on file. |
| Total raised $1.9M | attributed | sbir named as publisher. No document URL on file. |
| Company existence | self-reported | biotherapeuticsinc.com, read 2026-05-05 |
| Description | self-reported | biotherapeuticsinc.com, read 2026-05-05 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.